SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Karyopharm Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company was founded by Joseph Araujo, Ronald A. DePinho, Pamela A, Silver, Giulio Draetta, Michael G. Kauffman, and Sharon Shacham on December 22, 2008, and is headquartered in Newton, MA.

Karyopharm Therapeutics Inc

KPTI is trending due to concerns around the company's leadership and financial management. Community discussions focus on the performance of the CEO, potential mismanagement, and the need for strategic changes. Upcoming phase 3 results are a key factor for the company's future, amid discussions about its cash runway and potential need for further financing.

Caesars Entertainment, Inc. engages in the management of casinos and resorts under the Caesars, Harrah's, Horseshoe, and Eldorado brands. It operates through the following segments: Las Vegas, Regional, Caesars Digital, Managed and Branded, and Corporate and Other. The company was founded in 1937 and is headquartered in Reno, NV.

Caesars Entertainment Inc

CZR is trending as investors digest recent earnings results and debate the company's future prospects, particularly its debt load and growth strategy in a competitive market. Community discussions revolve around the impact of tariffs, potential for a recession, and the attractiveness of the stock's valuation relative to its digital assets and real estate. Some traders are closely watching for a potential bottom and possible actions from activist investors like Carl Icahn.

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

Zevra Therapeutics Inc

ZVRA is trending as rumors of potential acquisition swirl, with the community buzzing about a potential buyout after reports of a failed financing attempt from a smaller company.  Enthusiasm is building for the upcoming earnings report and the potential for a positive outcome, while some investors express skepticism toward management. Bullish sentiment is further fueled by high short interest, leading to speculation about a possible short squeeze.

Internet Computer (IC) is the world’s first blockchain that is capable of running at web speed at unrestrictive capacities. Built by the DFINITY Foundation, IC aims to recreate the web by supporting smart contract development at scale and changing the way people can interact using web services. Internet Computer aims to extend the public internet, so that it can be the world’s computing platform, in a decentralized manner. Internet Computer sets to revolutionalize the design of the crypto economy, with an aim to overhaul traditional software services.   The project was founded in October 2016 by Dominic WIllams and have raised a total of $121 million from investors such as Adreessen Horowitz, Polychain Capital, Multicoin Capital and such. On May 10, 2021, DFINITY launched the Internet Computer into the public domain, marking it a major milestone for ICP as it means the internet now functions as a decentralised global computer. This is marked by the release of all of the Internet Computer’s source code into the public domain, as well as ICP utility token that allows tens of thousands of community members to govern the Internet Computer network.  ICP is Internet Computer's native token. It plays three prominent roles:  1. Network Governance: Users that participate in the governance will be rewarded with ICPI 2. Production of Cycles for Compute: ICP can be converted into cycles where it is used as the transaction fee to access the network. Cycles are burned after used. 3. Rewarding Users: ICP is used as the rewards to incentivize users to participate in the network such as securing the network.

Internet Computer

Internet Computer (ICP) is trending amidst discussions about its underlying technology and potential for growth, with some community members highlighting its long-term vision to decentralize the internet and challenge established cloud providers. Bullish sentiment centers on its strong technology, recent launch of Caffeine AI, and staking rewards, while bears cite concerns about its historical performance, tokenomics, and adoption rates. Speculation about increased volume, potential partnerships, and integration of Bitcoin DeFi are also circulating within the community.

Hertz Global Holdings, Inc. engages in the vehicle rental business through the Hertz, Dollar, and Thrifty brands. It operates under the Americas Rental Car (RAC) and International Rental Car (RAC) segments. The Americas RAC segment focuses on operations in the United States, Canada, Latin America, and the Caribbean. The International RAC segment includes the provision of rental and sales of vehicles and value-added services in other locations. The company was founded in 1918 and is headquartered in Estero, FL.

Hertz Global Holdings Inc. - Ordinary Shares (New)

HTZ is trending due to a partnership with Amazon to sell used cars online, sparking discussions about its potential to challenge competitors like Carvana and boost retail visibility. The community is analyzing the potential for a short squeeze, fueled by high short interest and Ackman's involvement, while also considering the company's debt and upcoming earnings.

Altria Group, Inc. is a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral Tobacco Products, and All Other. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA, and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral Tobacco Products segment includes MST and snus products manufactured and sold by USSTC, and oral nicotine pouches manufactured and sold by Helix. The All Other segment refers to the financial results of NJOY, Helix ROW, and the IQOS System heated tobacco business. The company was founded in 1919 and is headquartered in Richmond, VA.

Altria Group Inc.

Altria Group ($MO) is trending as investors weigh its future amid shifting consumer habits and regulatory pressures. The community is discussing the growth potential of its oral tobacco segment, particularly the on! nicotine pouches, and evaluating its valuation relative to peers. Discussions also involve the company's dividend yield and its attractiveness as a defensive stock in a volatile market.

BioMarin Pharmaceutical, Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline products include Valoctocogene roxaparvovec, Vosoritide, and BMN 307. The company was founded by John C. Klock, Christopher M. Starr and Grant W. Denison on March 21, 1997, and is headquartered in San Rafael, CA.

Biomarin Pharmaceutical Inc. - Registered Shares

Biomarin Pharmaceutical is trending as traders discuss its deep-value territory and potential for call LEAPS. The community is weighing the risk-reward ratio and catalysts, including potential news or FDA activity, with some focusing on long-term opportunities while others express bearish sentiment due to concerns about momentum and lackluster performance.

Polkadot is a platform that allows diverse blockchains to transfer messages, including value, in a trust-free fashion; sharing their unique features while pooling their security. In brief, Polkadot is a scalable heterogeneous multi-chain technology.  Polkadot is heterogeneous because it is entirely flexible and makes no assumption about the nature or structure of the chains in the network. Even non-blockchain systems or data structures can become parachains if they fulfill a set of criteria.  Polkadot may be considered equivalent to a set of independent chains (e.g. a set containing Ethereum, Ethereum Classic, Namecoin and Bitcoin) except with important additions: pooled security and trust-free interchain transactability.  Many of the native parachains of Polkadot will be written using a Polkadot Runtime Environment SDK (e.g. Parity Technologies' Substrate).

Polkadot

Polkadot (DOT) is trending amid mixed sentiments, with some traders eyeing potential gains from staking and anticipating a broader altcoin rally, while others express frustration with the project's performance and leadership. Discussions include potential catalysts such as ETF approvals and interoperability solutions, alongside debates about its long-term viability and tokenomics. Community members are actively weighing the risks and opportunities surrounding DOT within the current market cycle.

DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. The company was founded by John F. Burd on May 13, 1999 and is headquartered in San Diego, CA.

Dexcom Inc

DXCM is trending downwards amidst concerns regarding the accuracy and reliability of its G7 continuous glucose monitor, highlighted in a recent short report. The community is discussing the potential impact of these issues on Dexcom's market share and the possibility of a class action lawsuit. Some traders believe the stock is oversold and presents a buying opportunity, while others are wary of negative sentiment and potential for further decline.

Trump For President

The Trump Crypto token is trending amid fluctuating prices, with community members debating its correlation to Bitcoin's movements and speculating on potential upside. Some traders are expressing bullish sentiment, while others cite the token's YTD performance and broader associations with political figures and meme coins. Discussions also include mentions of potential lawsuits, market manipulation, and the token's use in fundraising efforts.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

InterCure (INCR) on Friday announced that it will acquire premium medical cannabis technology and brand company Botanico, also known as ISHI. &nbsp;The company <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/news-release/2025/09/19/3153163/0/en/InterCure-Announces-Strategic-Acquisition-of-ISHI-Unlocking-Access-to-Premium-U-S-Cannabis-Technology-and-Brands.html">said</a> that it would acquire ISHI in two phases. The company would initially acquire 50% of equity for about 2.47 million InterCure ordinary shares. The remaining 50% will be acquired either 24 months from the initial closing, in consideration for an additional 2.46 million InterCure ordinary shares, or upon ISHI achieving positive operating profitability for at least three consecutive months, InterCure said.<a href="https://stocktwits.com/symbol/INCR">INCR stock</a> traded 2% higher at the time of writing. On Stocktwits, retail sentiment around INCR stayed within the ‘extremely bullish’ territory over the past 24 hours, while message volume stayed at ‘extremely high’ levels.InterCure said that the acquisition comes as the Trump administration reportedly explores the rescheduling of cannabis from Schedule I to Schedule III. This regulatory shift could unlock unprecedented opportunities for international cannabis companies such as InterCure, it added.InterCure stated that the acquisition would provide access to ISHI's premium indoor product supply, brand portfolio, technology, and operational systems, which will enhance the former’s supply chain and distribution operations while supporting expansion into international markets. The company will also gain access to exclusive partnerships with premium U.S. brands, such as medical cannabis company The Flowery.Following the acquisition, ISHI founders Omer Layani and Dor Hershkovitz will join the InterCure leadership team, and all existing ISHI stock options will be converted to InterCure options, maintaining the original vesting schedules."By acquiring ISHI, we gain immediate access to some of America's most sought-after cannabis genetics and proven operational technologies at exactly the moment when we are encouraged by the reported recent momentum in the U.S. around potential cannabis rescheduling,” said CEO Alexander Rabinovich, while adding that the company expects it to become accretive to its business model within the first year.The transaction is expected to close in the first quarter of 2026, subject to regulatory approvals.INCR stock has fallen 4% this year and by approximately 18% over the past 12 months.&nbsp;Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/intellia-therapeutics-stock-gets-price-target-hike-from-hc-wainwright/chD3TDgR3Rw">Intellia Therapeutics Stock Gets A Price Target Hike From HC Wainwright – Check Out The Details</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Global stock market chart and trading board - stock photo

InterCure To Buy ISHI In All-Stock Transaction – Find Out More

The company said that it would acquire ISHI in two phases for a total consideration of 4.92 million shares. 

Equity

InterCure Names Alexander Rabinovich as Chairman Replacing Ehud Barak

InterCure Names Alexander Rabinovich as Chairman Replacing Ehud Barak InterCure Names Alexander Rabinovich as Chairman Replacing Ehud Barak PR Newswire NEW YORK and HERZLIYA, Israel, Feb. 12, 2025...

InterCure Announces Expansion of its Strategic partnership with Cookies to Germany

InterCure Ltd. (NASDAQ: INCR) (TASE: INCR) (dba Canndoc) ('InterCure' or the 'Company'), the leading vertically integrated medical cannabis company outside of North America, is announcing a new...

InterCure to Participate in Canaccord Genuitys 8th Annual Global Cannabis Conference

InterCure Ltd. (NASDAQ: INCR) (TASE: INCR) (dba Canndoc), the leading medical cannabis company outside of North America, today announced that it will participate in the Canaccord Genuity 8th Annual...

InterCure Reports Strong FY2023: Performance Paves the Way for Global Expansion

'Explore InterCure's FY2023 financial results revealing robust revenue growth and operational resilience amidst challenges.
read more...

InterCure Announces FY2023 Results: Revenue of NIS 356 million and Adjusted EBITDA of NIS 61 million

InterCure Ltd. (NASDAQ: INCR) (TASE: INCR) ('InterCure' or the 'Company') today announced results for the full year ending December 31, 2023. All amounts are expressed in New Israeli Shekels (NIS...

Intercure Ltd. Submits SEC Compliance Report

Intercure (IL:INCR) has released an update. Intercure Ltd., an Israel-based company, has submitted its monthly report to the SEC, affirming its adh...

InterCure Announces Preliminary Estimated 2023 Revenue of NIS 351 million and EBITDA of over NIS 50 million

InterCure Ltd. (NASDAQ: INCR) (TASE: INCR) ('InterCure' or the Company) today announced preliminary results for the full year of 2023. All amounts are expressed in New Israeli Shekels (NIS), unless...

InterCure Congratulates Germany on Cannabis Reform, Expanding its Global Footprint

InterCure Ltd. (NASDAQ: INCR) (TASE: INCR) (dba Canndoc) ('InterCure' or the 'Company'), the leading medical cannabis company outside of North America, is thrilled to congratulate...

InterCure Provides an Update Regarding Nir Oz Facility

NEW YORK, and HERZLIYA, Israel, Feb. 13, 2024 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TASE: INCR) (dba Canndoc) ("InterCure" or the "Company"), the leading medical cannabis company in...

InterCure Ltd. engages in the provision of business of medical cannabis and biomedicine. It operates through the Investments in Biomed Portfolio Companies in the Biomed Sector and Investments in the Medical Cannabis Sector segments. The company was founded by Benjamin Gavish and Erez Gavish on November 20, 1994 and is headquartered in Herzliya, Israel.

Intercure Ltd

Will Palantir ($PLTR) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

Palantir Technologies Inc

) beat quarterly earnings? 
 
*Powered by Polymarket

Current Price	$1.40
Prev Close	$1.40
Open	$1.41
Dividend Yield	0.00%
50-Day Moving Average	$1.55
Beta	0.75
Avg. Volume	124,620.00
PE Ratio	N/A

52-Week High	$1.79
52-Week Low	$1.17
Market Capitalization	$251.58M
EPS (Annual)	-$0.3993
Price to Book	0.52
Revenue Per Employee	$201,635.80
Enterprise Value/EBITDA	N/A

INCR
Intercure Ltd

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest INCR News

INCRIntercure Ltd